Vita 34 AG Stock
Your prediction
Vita 34 AG Stock
A loss of -2.320% shows a downward development for Vita 34 AG.
Criterium "Market Position" is seen as the biggest plus for Vita 34 AG stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vita 34 AG in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vita 34 AG vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vita 34 AG | -2.320% | 1.068% | -2.675% | 15.931% | -22.459% | -24.682% | -69.484% |
| M1 Kliniken AG | 6.450% | 2.756% | -1.136% | 5.384% | -18.438% | 118.106% | 29.421% |
| Mediclin AG | 1.160% | 0.000% | -4.372% | 20.690% | -2.235% | 10.759% | -19.725% |
| Healthstream Inc. | 0.000% | -3.429% | -7.143% | -39.643% | -13.333% | -30.738% | -7.650% |
News
EQS-News: FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues
EQS-News: FamiCord AG accelerates profitable growth in the third quarter of 2025 and further strengthens quality and visibility of revenues
